Number of shares outstanding for Enanta Pharmaceuticals (ENTA)

Number of shares outstanding as of September 2024 : 21,180,000

According to Enanta Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 21,180,000. At the end of 2024 the company had 21,180,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Enanta Pharmaceuticals from 2011 to 2024

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2024	21.18 M	0.44%
2023	21.08 M	1.31%
2022	20.81 M	2.1%
2021	20.38 M	1.47%
2020	20.09 M	1.73%
2019	19.75 M	1.67%
2018	19.42 M	1.55%
2017	19.13 M	0.48%
2016	19.03 M	1.4%
2015	18.77 M	0.93%
2014	18.6 M	3.64%
2013	17.94 M	1449.97%
2012	1.15 M	-90.96%
2011	12.81 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
AbbVie ABBV	1,768,000,000	8,247.50%	🇺🇸 USA
Johnson & Johnson JNJ	2,406,800,000	11,263.55%	🇺🇸 USA
Vertex Pharmaceuticals VRTX	258,100,000	1,118.60%	🇺🇸 USA
Merck MRK	2,535,649,470	11,871.90%	🇺🇸 USA
Bristol-Myers Squibb BMY	2,027,000,000	9,470.35%	🇺🇸 USA
Novartis NVS	2,033,000,000	9,498.68%	🇨🇭 Switzerland

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is receiving financial compensation for Delta App installs.
CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions